Maggot débridement therapy in outpatients.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 11552195.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To identify the benefits, risks, and problems associated with outpatient maggot therapy. Descriptive case series, with survey. Urban and rural clinics and homes. Seven caregivers with varying levels of formal health care training and 21 ambulatory patients (15 men, 6 women; average age, 63 yr) with nonhealing wounds. Maggot therapy. Therapists' opinions concerning clinical outcomes and the disadvantages of therapy. More than 95% of the therapists and 90% of their patients were satisfied with their outpatient maggot débridement therapy. Of the 8 patients who were advised to undergo amputation or major surgical débridement as an alternative to maggot débridement, only 3 required surgical resection (amputation) after maggot therapy. Maggot therapy completely or significantly débrided 18 (86%) of the wounds; 11 healed without any additional surgical procedures. There was anxiety about maggots escaping, but actual escapes were rare. Pain, reported by several patients, was controlled with oral analgesics. Outpatient maggot débridement is safe, effective, and acceptable to most patients, even when administered by nonphysicians. Maggot débridement is a valuable and rational treatment option for many ambulatory, home-bound, and extended care patients who have nonhealing wounds.
Medical subject headings
- Ambulatory Care
- Debridement
- Larva
- Skin Ulcer
- Wounds and Injuries